CN102415462A - Health-preserving health-care tea - Google Patents
Health-preserving health-care tea Download PDFInfo
- Publication number
- CN102415462A CN102415462A CN2011104228757A CN201110422875A CN102415462A CN 102415462 A CN102415462 A CN 102415462A CN 2011104228757 A CN2011104228757 A CN 2011104228757A CN 201110422875 A CN201110422875 A CN 201110422875A CN 102415462 A CN102415462 A CN 102415462A
- Authority
- CN
- China
- Prior art keywords
- broomrape
- stevioside
- health
- water
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001122767 Theaceae Species 0.000 title description 19
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 23
- 229940013618 stevioside Drugs 0.000 claims abstract description 23
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 23
- 235000019202 steviosides Nutrition 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000001035 drying Methods 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 7
- 238000009835 boiling Methods 0.000 claims abstract description 6
- 239000012535 impurity Substances 0.000 claims abstract description 6
- 238000004140 cleaning Methods 0.000 claims abstract description 3
- 244000269722 Thea sinensis Species 0.000 claims abstract 5
- 241000336315 Cistanche salsa Species 0.000 claims description 32
- 230000036541 health Effects 0.000 claims description 21
- 239000012141 concentrate Substances 0.000 claims description 18
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 244000178231 Rosmarinus officinalis Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 16
- 206010003549 asthenia Diseases 0.000 abstract description 6
- 208000007443 Neurasthenia Diseases 0.000 abstract description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 5
- 230000004064 dysfunction Effects 0.000 abstract description 5
- 206010022437 insomnia Diseases 0.000 abstract description 5
- 241000196324 Embryophyta Species 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 210000000653 nervous system Anatomy 0.000 abstract description 2
- 241000005787 Cistanche Species 0.000 abstract 2
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 210000000750 endocrine system Anatomy 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000000643 oven drying Methods 0.000 abstract 1
- 230000002028 premature Effects 0.000 abstract 1
- 239000001331 rosmarinus officinalis leaf Substances 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
- 210000001835 viscera Anatomy 0.000 abstract 1
- 241001529742 Rosmarinus Species 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- 230000009278 visceral effect Effects 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000034657 Convalescence Diseases 0.000 description 2
- 208000014540 Functional gastrointestinal disease Diseases 0.000 description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- XUSYGBPHQBWGAD-PJSUUKDQSA-N Carnosol Chemical compound CC([C@@H]1C2)(C)CCC[C@@]11C(=O)O[C@@H]2C2=C1C(O)=C(O)C(C(C)C)=C2 XUSYGBPHQBWGAD-PJSUUKDQSA-N 0.000 description 1
- MMFRMKXYTWBMOM-UHFFFAOYSA-N Carnosol Natural products CCc1cc2C3CC4C(C)(C)CCCC4(C(=O)O3)c2c(O)c1O MMFRMKXYTWBMOM-UHFFFAOYSA-N 0.000 description 1
- 241000189115 Catananche Species 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- -1 alum Chemical compound 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001663 anti-spastic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000008344 brain blood flow Effects 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000004654 carnosol Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000002554 disease preventive effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930003935 flavonoid Chemical group 0.000 description 1
- 150000002215 flavonoids Chemical group 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229910052746 lanthanum Inorganic materials 0.000 description 1
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a preparation of medicinal plants and tea, in particular to health-care tea, which comprises the following steps: (1) taking 3-5 parts of rosemary leaf and 5-10 parts of herba cistanche, removing impurities, and cleaning; (2) and (3) drying: removing water on the surface of the medicinal material in the step (1); (3) crushing cistanche, treating with microwave at medium-high fire for 90s, adding water, and mixing the following materials in a ratio of: 1:20, extracting with boiling water for 90min, filtering, and concentrating to obtain herba Boschniakiae Rossicae concentrated solution; (4) dissolving 1 part of stevioside in water to obtain a stevioside solution; (5) spraying the herba Boschniakiae Rossicae concentrated solution and stevioside solution on the surface of herba Rosmarini officinalis leaf, and oven drying to reach quality-keeping dryness. The invention can relieve and eliminate sub-health states of insomnia, neurasthenia, premature senility, asthenia, viscera dysfunction and the like, and has good effects on patients in cardiovascular and cerebrovascular systems, nervous systems, endocrine systems, valetudinarianism and rehabilitation stages after illness.
Description
Technical field
The present invention relates to the preparation of a kind of medicinal plant and tea, specifically is a kind of health care tea.
Background technology
At present, along with the internationalization in market, the pressure of people in modern work is increasing, and sub-health status such as weary unable, the visceral dysfunction of insomnia, neurasthenia in various degree, prematurely senile, body appear in increasing people.Not finding symptom because inferior health is meant in examination in hospital, chemical examination, but feel uncomfortable, is the low state of physiological function between health and disease.Therefore, use the bigger drug therapy of side effect just to seem unreasonable to sub-health population.Show according to World Health Organization's investigation: whole world healthy population has 15% approximately, and unhealthy crowd has 15% approximately, and about 70% crowd is in sub-health state.Therefore, the health status of improving the sub-health population of weary unable, the visceral dysfunction of insomnia, neurasthenia, prematurely senile, body seems significant.
Summary of the invention
The present invention is directed to the sub-health population of weary unable, the visceral dysfunction of insomnia, neurasthenia, prematurely senile, weak and sickly, body, a kind of health care tea is provided.
The present invention adopts following technical scheme to realize: a kind of health care tea, and its manufacture craft may further comprise the steps: rosemary leave 3-5 part, broomrape 5-10 part are got in (1), remove impurity, clean up; (2) drying: the moisture of removing the medicinal material surface of step (1); (3) broomrape is pulverized, high fire is handled 90s in the microwave, adds water, solid-liquid ratio: 1:20, and extracting in boiling water 90min filters, and concentrates, and obtains the broomrape concentrate; (4) it is water-soluble to get 1 part of stevioside, obtains stevioside solution; (5) broomrape concentrate and stevioside solution are sprayed in the rosemary leave surface, oven dry reaches the mass dryness fraction of guaranteeing the quality.
Further, the equipment of the cleaning of described step (1) employing is medicine-washing machine.
Further, the equipment of the drying of described step (2) employing is micro-wave oven or other tea-drying equipment.Said baking temperature adopts conventional tealeaves baking temperature.
In the microwave in the described step (3) high fire handle use be the WCD07S microwave abstracting equipment produced by Sanle Microwave Technology Development Co., Ltd, Nanjing in high fire screen position.The purpose of described microwave treatment is to destroy plant cell, improves effective component extraction rate.
The concentration of the solid content of the broomrape concentrate that said step (3) obtains and the described stevioside solution of step (4) all can height can be low; If identical temperature is adopted in step (5) oven dry; When the concentration of the solid content of broomrape concentrate and stevioside solution was higher, it is shorter that oven dry reaches the time of the mass dryness fraction of guaranteeing the quality; On the contrary, when the concentration of the solid content of broomrape concentrate and stevioside solution was low, it is longer that oven dry reaches time of the mass dryness fraction of guaranteeing the quality.The bake out temperature of described step (5) adopts the bake out temperature of conventional preparation tealeaves.
The described mass dryness fraction of guaranteeing the quality is for if can only be ground into disconnected bar shaped, explaining that the mass dryness fraction of tea is not enough with the tea grind into fine powder with two fingers, and water content is too high, is prone to ageing, is prone to mouldy.
Rosemary: medical research confirms that rosemary, can extract anti-oxidant, Rosemary Oil and the multiple former medicine intermediate of removing oxygen radical in the body.Rosmarinus officinalis extract is rich in the natural activity composition: rosemary, phenol, carnosol, Rosmarinic acid and volatilization wet goods; They all contain adjacent phenol structure and flavonoids composition; Very strong oxidation resistance and anti-microbial effect are arranged, and the protection liver arranged, produce refreshing effect to the mind, the effect of antiasthmatic-antitussive, anti-inflammatory antispastic, convergence wind dispelling, toxin-expelling and face nourishing.For cardio-cerebrovascular, respiratory system, digestive system and immunity, endocrine system disease preventive and therapeutic effect is arranged.Rosemary, is rich in active zinc in addition, and enhances human body memory is had special role.
The main chemical of broomrape has: isolate 15 kinds of compounds such as n-hexane base vinyl alcohol in broomrape alkali, broomrape ketone and the broomrape volatile oil.Research confirms to contain 17 seed amino acids such as propylhomoserin, methionine in the broomrape, must amino acid comprising seven kinds of human bodies.The inorganic elements of broomrape is measured and is contained more calcium, magnesium, phosphorus, aluminium, sodium; Also contain and plant trace element surplus cobalt, alum, chromium, lanthanum, manganese, the titanium etc. ten.Pharmacological research finds that broomrape has following pharmacological action: raise immunity, remove in oxygen radical, anti-ageing, antitumor, anti-inflammatory, antifatigue, the enhancing body anoxic ability and improve brain tissue blood circulation ability.The traditional Chinese medical science thinks that broomrape (popular name old grass) has strengthening by means of tonics, prolongs life, tonifies the kidney and support yang, the effect of ease constipation hemostasis.Cure mainly: impotence due to deficiency of the kidney, waist knee crymodynia, habitual constipation, cystitis etc.; Use proper, without any side effects.
Described stevioside is the new type natural sweetener that essence is carried from catananche's STEVIA REBAUDIANA, and it has the characteristics of high sugariness, low heat energy, can suppress peculiar smell, the strange taste of medicine, makes that the bright refreshing flavor of health care tea of the present invention is pure, mellow and full agreeable to the taste.
The present invention is made up by rosemary,, broomrape and stevioside to be made according to a certain weight ratio; After live and work, often drink; Can alleviate and eliminate sub-health states such as weary unable, the visceral dysfunction of insomnia, neurasthenia, prematurely senile, body; The present invention simultaneously has good effect to cardio-cerebrovascular, nervous system, internal system, patient weak and sickly and convalescence; In addition, the present invention also have anti-ageing, anticancer, caring skin, relieving asthma, the effect of cough-relieving.
Experiment one: the effect of health care tea of the present invention is observed:
This experiment is collected altogether and is met neurastheniac's 80 examples, through the investigation age between 16-58 years old, March time of all having a sleepless night is above and the phenomenon of failure of memory arranged.At random 80 patients are divided into two groups, wherein 40 examples are for the treatment group, and 40 examples are control group, and the treatment group is drunk health care tea of the present invention every day 3 times, and control group is done blank test.
After 2 weeks, observe its effect, through statistical procedures, treatment group total effective rate is 98.1%, with control group significant difference (P＜0.01) is arranged relatively before and after the treatment.
Experiment two: the effect of health care tea of the present invention is observed:
This experiment is collected altogether and is met Functional Gastrointestinal Disorder (FGID) patient 250 examples, selects treatment to organize 150 examples at random, control group 100 examples.
Treatment group: male patient's 105 examples, female patient 45 examples, 31.2 ± 0.18 years old mean age, course of disease 0.21-5, average 0.26 ± 0.15 year.
Control group: male patient's 70 examples, female patient 30 examples, 18-70 years old ages, 43.1 ± 0.12 years old mean age.
The treatment group is drunk health care tea of the present invention, and the control group routine is taken medicine for stomach dynamic and Chinese medicine.Effect is observed: two groups of curative effect scoring contrasts all have existing difference (P＜0.01) before and after the treatment, but the treatment group is than control group curative effect more obvious (P＜0.01).
Experiment three: the effect of health care tea of the present invention is observed:
This experiment is collected altogether and is met cerebral thrombus forming patient's 40 examples, through 40-70 years old ages of investigation, and male patient's 29 examples wherein, female patient 11 examples are cerebral thrombosis subacute stage, convalescence hemiplegic patient.All drink health care tea of the present invention, every day 3 times, drink February after, follow-up investigation: cure 9 examples, 27 examples that take a turn for the better, 4 examples more, total effective rate 91%.The result shows, drinks health care tea of the present invention and can improve the brain blood circulation, promote cerebral tissue function to recover.
The specific embodiment
Embodiment 1: every part is 1 gram.
A kind of health care tea, its manufacture craft may further comprise the steps: rosemary leave 3 grams, broomrape 7 grams are got in (1), remove impurity, clean up; (2) drying: the moisture of removing the medicinal material surface of step (1); (3) broomrape is pulverized, high fire is handled 90s in the microwave, adds water 140 grams, and extracting in boiling water 90min filters, and concentrates, and obtains the broomrape concentrate; (4) it is water-soluble to get stevioside 1 gram, obtains stevioside solution; (5) broomrape concentrate and stevioside solution are sprayed in the rosemary leave surface, oven dry reaches the mass dryness fraction of guaranteeing the quality.
Embodiment 2: every part is 1 jin.
A kind of health care tea, its manufacture craft may further comprise the steps: 4 jin of rosemary leaves, 10 jin of broomrapes are got in (1), remove impurity, clean up; (2) drying: the moisture of removing the medicinal material surface of step (1); (3) broomrape is pulverized, high fire is handled 90s in the microwave, adds 200 jin in water, and extracting in boiling water 90min filters, and concentrates, and obtains the broomrape concentrate; (4) it is water-soluble to get 1 jin of stevioside, obtains stevioside solution; (5) broomrape concentrate and stevioside solution are sprayed in the rosemary leave surface, oven dry reaches the mass dryness fraction of guaranteeing the quality.
Embodiment 3:Every part is 1 kilogram.
A kind of health care tea, its manufacture craft may further comprise the steps: 5 kilograms of rosemary leaves, 5 kilograms of broomrapes are got in (1), remove impurity, clean up; (2) drying: the moisture of removing the medicinal material surface of step (1); (3) broomrape is pulverized, high fire is handled 90s in the microwave, adds the water double centner, and extracting in boiling water 90min filters, and concentrates, and obtains the broomrape concentrate; (4) it is water-soluble to get 1 kilogram of stevioside, obtains stevioside solution; (5) broomrape concentrate and stevioside solution are sprayed in the rosemary leave surface, oven dry reaches the mass dryness fraction of guaranteeing the quality.
Claims (3)
1. a health care tea is characterized in that, its manufacture craft may further comprise the steps: rosemary leave 3-5 part, broomrape 5-10 part are got in (1), remove impurity, clean up; (2) drying: the moisture of removing the medicinal material surface of step (1); (3) broomrape is pulverized, high fire is handled 90s in the microwave, adds water, solid-liquid ratio: 1:20, and extracting in boiling water 90min filters, and concentrates, and obtains the broomrape concentrate; (4) it is water-soluble to get 1 part of stevioside, obtains stevioside solution; (5) broomrape concentrate and stevioside solution are sprayed in the rosemary leave skin drying, reach the mass dryness fraction of guaranteeing the quality.
2. health care tea according to claim 1 is characterized in that, the equipment that the cleaning of described step (1) is adopted is medicine-washing machine.
3. health care tea according to claim 1 and 2 is characterized in that, the equipment that the drying of described step (2) adopts is micro-wave oven or other tea-drying equipment.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110422875 CN102415462B (en) | 2011-12-16 | 2011-12-16 | Health care tea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110422875 CN102415462B (en) | 2011-12-16 | 2011-12-16 | Health care tea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102415462A true CN102415462A (en) | 2012-04-18 |
| CN102415462B CN102415462B (en) | 2012-12-26 |
Family
ID=45940303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110422875 Expired - Fee Related CN102415462B (en) | 2011-12-16 | 2011-12-16 | Health care tea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102415462B (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103652175A (en) * | 2013-11-27 | 2014-03-26 | 湖州立方农艺科技发展有限公司 | Health-care tea |
| CN103815089A (en) * | 2012-11-16 | 2014-05-28 | 郭天伊 | Preparation method of Boschniakia rossica health tea |
| CN103815084A (en) * | 2012-11-16 | 2014-05-28 | 邢秋苓 | Preparation method for boschniakia rossica barley tea |
| CN104686751A (en) * | 2015-02-13 | 2015-06-10 | 高深 | Compound tea and preparation method thereof |
| CN105961974A (en) * | 2016-05-26 | 2016-09-28 | 胡志荣 | Method for making boschniakia rossica healthcare drink |
| CN107136260A (en) * | 2017-05-05 | 2017-09-08 | 李佳威 | Health protection tea and preparation method and application |
| CN112790262A (en) * | 2020-12-28 | 2021-05-14 | 淄博市农业科学研究院 | Chrysanthemum tea making method and chrysanthemum tea |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10257867A (en) * | 1997-03-19 | 1998-09-29 | Nisshin Oil Mills Ltd:The | Food for improving hypoalbuminaemia |
| WO2001013734A1 (en) * | 1999-08-20 | 2001-03-01 | Nam Jong Hyun | A natural tea for curing men's impotence and a method for manufacturing the same |
| CN101151986A (en) * | 2006-09-25 | 2008-04-02 | 赵云峰 | Health tea |
| CN101156636A (en) * | 2007-11-06 | 2008-04-09 | 米永红 | A seal wort and lily pure and fresh tea |
| CN101214000A (en) * | 2007-12-26 | 2008-07-09 | 肖自力 | Health preserving health tea for female intestinal canal |
| CN101731386A (en) * | 2010-01-11 | 2010-06-16 | 钟华安 | Health-preserving and health-care tea and preparation method thereof |
| CN101889619A (en) * | 2010-07-26 | 2010-11-24 | 华侨大学 | Health-care tea and preparation method thereof |
-
2011
- 2011-12-16 CN CN 201110422875 patent/CN102415462B/en not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10257867A (en) * | 1997-03-19 | 1998-09-29 | Nisshin Oil Mills Ltd:The | Food for improving hypoalbuminaemia |
| WO2001013734A1 (en) * | 1999-08-20 | 2001-03-01 | Nam Jong Hyun | A natural tea for curing men's impotence and a method for manufacturing the same |
| CN101151986A (en) * | 2006-09-25 | 2008-04-02 | 赵云峰 | Health tea |
| CN101156636A (en) * | 2007-11-06 | 2008-04-09 | 米永红 | A seal wort and lily pure and fresh tea |
| CN101214000A (en) * | 2007-12-26 | 2008-07-09 | 肖自力 | Health preserving health tea for female intestinal canal |
| CN101731386A (en) * | 2010-01-11 | 2010-06-16 | 钟华安 | Health-preserving and health-care tea and preparation method thereof |
| CN101889619A (en) * | 2010-07-26 | 2010-11-24 | 华侨大学 | Health-care tea and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 朴龙等: "草苁蓉提取物抗衰老作用的研究", 《中国老年学杂志》 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103815089A (en) * | 2012-11-16 | 2014-05-28 | 郭天伊 | Preparation method of Boschniakia rossica health tea |
| CN103815084A (en) * | 2012-11-16 | 2014-05-28 | 邢秋苓 | Preparation method for boschniakia rossica barley tea |
| CN103652175A (en) * | 2013-11-27 | 2014-03-26 | 湖州立方农艺科技发展有限公司 | Health-care tea |
| CN104686751A (en) * | 2015-02-13 | 2015-06-10 | 高深 | Compound tea and preparation method thereof |
| CN105961974A (en) * | 2016-05-26 | 2016-09-28 | 胡志荣 | Method for making boschniakia rossica healthcare drink |
| CN107136260A (en) * | 2017-05-05 | 2017-09-08 | 李佳威 | Health protection tea and preparation method and application |
| CN112790262A (en) * | 2020-12-28 | 2021-05-14 | 淄博市农业科学研究院 | Chrysanthemum tea making method and chrysanthemum tea |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102415462B (en) | 2012-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102415462B (en) | Health care tea | |
| CN101317615B (en) | Silver-thorn tea beverage and preparation method thereof | |
| CN104856035A (en) | Health-care product for recuperating specific intrinsic constitution | |
| CN102613566B (en) | Health care product for relaxing bowel and preparation method of heath care product | |
| KR20130029098A (en) | Mathod for manufacturing ion mineral using silk worm, muberry leaf, and muberry twig and health drink manufactured by this | |
| CN103768567B (en) | A kind of black plaster and preparation method thereof | |
| CN102657278A (en) | Asparagus healthcare tea | |
| CN102204610B (en) | Gingko health-care tea | |
| CN102920806B (en) | Nerve-soothing blood-pressure-reducing traditional Chinese medicine tea | |
| CN104815192A (en) | Pharmaceutical composition for treating hypertension and application of pharmaceutical composition | |
| CN103182051B (en) | Health tea with stomach protection function and preparation method thereof | |
| CN101804110B (en) | Traditional Chinese medicine preparation for thrombosis and blood lipid | |
| CN105213256A (en) | A kind of Shu Min dispels red toner/smoothing toner and preparation method thereof | |
| CN108813501A (en) | With the relieving cough and reducing sputum health honey paste relievingd asthma and adjust function of human body of clearing heat and moistening lung | |
| CN102422938B (en) | Tea for preventing and treating elderly constipation and preparation method thereof | |
| CN104083438A (en) | Balsam pear-containing traditional Chinese medicinal preparation for alleviating hypertension, and preparation method thereof | |
| KR101045025B1 (en) | Pharmaceutical composition for preventing or treatment of asthma | |
| CN105709020A (en) | Foot bath powder with folium artemisiae argyi decoction dregs and preparation method thereof | |
| CN103948021A (en) | Dendranthema morifolium (ramat.) tzvel cv.chuju eyesight-improving health granules and production method thereof | |
| CN102669340A (en) | Food blood nourishing tea granule for relieving alimentary anemia | |
| CN101491641B (en) | Traditional Chinese medicine for treating cancer | |
| CN104013728B (en) | Chinese medicine preparation of a kind of Treatment of Herpes Zoster and preparation method thereof | |
| CN102552410A (en) | Medicine for treating hypertension disease and preparation method thereof | |
| CN105663445A (en) | Production process of tea nucleic acid for reducing high blood pressure, high blood lipid and high blood sugar and preventing and treating cardiovascular and cerebrovascular diseases | |
| CN107047881A (en) | Health composition, health protection tea and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121226 Termination date: 20191216 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |